This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC.
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Chronic urticaria (CU), also referred to as chronic idiopathic urticaria or chronic spontaneous urticaria is an intensely-pruritic inflammatory skin disorder. Chronic urticaria can last from 6 weeks to several years, and often has a profound negative impact on patients’ quality of life. Chronic urticaria is often considered a notoriously difficult condition to treat. Treatment decisions can be clouded by confusion amongst clinicians regarding evidenced-based treatment guidelines, excessive reliance on personal experience and anecdotal information, and lack of familiarity or comfort with newer therapeutic options.
US-based allergy/immunology and dermatology clinicians
After completing the activity, the participant should be better able to:
Recognize physical exam findings and symptomatology suggestive of chronic urticaria (CU) and appropriately apply evidence-based practices regarding diagnostic testing and laboratory workup
Utilize a guideline-driven approach to treatment intensification for safe and effective management of CU patients in need of second- and third-line treatment options, while taking into account quality of life issues
Conflict Of Interest Disclosure Policies
The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Anne Marie Ditto, MD Associate Professor of Medicine Division of Allergy-Immunology Northwestern University Feinberg School of Medicine Chicago, IL
Dr. Ditto has no affiliations with commercial interests to disclose.
Luz Fonacier, MD, FAAAAI, FACAAI Professor of Medicine State University of New York at Stony Brook Stony Brook, NY Head of Allergy Program Director, Allergy and Immunology Fellowship Program NYU Winthrop Hospital Mineola, NY
Dr. Fonacier has affiliations with Regeneron (Consulting Fees); Regeneron (Speakers Bureaus); Pfizer, Regeneron, Shire (Contracted Research).
Accredited Provider Disclosures
The PIM planners and managers have nothing to disclose. RMEI Medical Education, LLC planners and managers have nothing to disclose.
AMA PRA Category 1 Credit(s)TM
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and PAs are entitled to receive up to 0.75 AMA PRA Category 1 Credit(s)TM . A statement of credit will be available to print immediately. Users must:
Read the learning objectives and faculty disclosures.
Participate in the activity.
Complete the activity evaluation.
Physicians, nurse practitioners, and PAs who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.